Cardio Diagnostics Holdings, Inc. — Form 10-Q
Filed August 7, 2026 · analyzed by the Periodic Agent
10-Q
— Neutral
significance 3/100
What the filing says
CEO Meeshanthini V. Dogan and CFO Elisa Luqman certified the Q2 2026 10-Q on August 7, 2026, attesting to compliance with disclosure controls, internal control effectiveness, and fair presentation of financial statements. No material weaknesses, deficiencies, or fraud were disclosed. This is routine executive certification required by Sarbanes-Oxley.
Why this rating
Boilerplate quarterly executive certification; no operational, financial, or strategic changes disclosed or implied.
See more from August 7, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.